INSITU BIOLOGICS, INC. HAS REQUESTED THAT THE OMITTED PORTIONS OF THIS DOCUMENT, WHICH ARE INDICATED BY ASTERISKS, BE ACCORDED CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 UNDER THE SECURITIES ACT OF 1933. INSITU BIOLOGICS, INC. HAS SEPARATELY FILED...License Agreement • July 16th, 2018 • InSitu Biologics, Inc • Pharmaceutical preparations • Minnesota
Contract Type FiledJuly 16th, 2018 Company Industry JurisdictionTHIS LICENSE AGREEMENT (this “License Agreement”) is made and entered into as of November 14, 2014 (the “Effective Date”) by and between Lifecore Biomedical, LLC (“Lifecore”) and InSitu Biologics, Inc. (“ISB”).
INSITU BIOLOGICS, INCORPORATED WARRANT TO PURCHASE SHARESInSitu Biologics, Inc • June 5th, 2018 • Pharmaceutical preparations • Delaware
Company FiledJune 5th, 2018 Industry JurisdictionThis Warrant is issued to _________________ (“NAME”) by InSitu Biologics, Incorporated, a Delaware corporation (the “Company”), in connection with revenues received from HDS.
INSITU BIOLOGICS, INCORPORATED WARRANT TO PURCHASE SHARESLicense Agreement • May 10th, 2018 • InSitu Biologics, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMay 10th, 2018 Company Industry JurisdictionThis Warrant is issued to _________________ (“NAME”) by InSitu Biologics, Incorporated, a Delaware corporation (the “Company”), in connection with revenues received from HDS.